Pharma & Healthcare
Drug approvals, USFDA actions, hospitals and diagnostics.
Sun Pharma Adv.Res.Co.Ltd Share Price Dropped 3.45% to ₹173.09 on Fundraise News — What It Means for Investors
Sun Pharma Adv.Res.Co.Ltd (SPARC) last traded at ₹173.09, -6.18 (-3.45%) as the fundraise story plays out. Last-session board, day range, twelve-month context and the follow-up that decides the next session.
Fundraise Story Puts Sun Pharma Adv.Res.Co.Ltd in Play: Share Price Closed Lower at ₹185.07, and Here Is the Arithmetic
Sun Pharma Adv.Res.Co.Ltd (SPARC) last traded at ₹185.07, -3.57 (-1.89%). The fundraise trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
NATCOPHARM in Focus: Natco Pharma Share Price Closed Higher at ₹800.85 in the News Today
Natco Pharma (NATCOPHARM) last traded at ₹800.85, +15.80 (+2.01%) as the in-focus story plays out. Last-session board, day range, twelve-month context and the follow-up that decides the next session.
TORNTPHARM in Focus: Torrent Pharmaceuticals Share Price Closed Lower at ₹4,558.90 in the News Today
Torrent Pharmaceuticals (TORNTPHARM) last traded at ₹4,558.90, -25.20 (-0.55%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Mankind Pharma Share Price Closed Higher at ₹2,347.60 on Block Deal News — What It Means for Investors
Mankind Pharma (MANKIND) last traded at ₹2,347.60, +12.60 (+0.54%). The block-deal trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
MANKIND Closed Higher at ₹2,347.60: Inside the Block Deal Story Moving Mankind Pharma Shares
Mankind Pharma (MANKIND) last traded at ₹2,347.60, +12.60 (+0.54%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Jubilant Pharmova Jumped 3.55% to ₹965.00 After Block Deal Update — Levels, Volumes and the Follow-Up to Track
Jubilant Pharmova (JUBLPHARMA) last traded at ₹965.00, +33.10 (+3.55%). The block-deal trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Fundraise Story Puts Sun Pharma Adv.Res.Co.Ltd in Play: Share Price Traded Flat at ₹197.00, and Here Is the Arithmetic
Sun Pharma Adv.Res.Co.Ltd (SPARC) last traded at ₹197.00, +0.11 (+0.06%) as the fundraise story plays out. Last-session board, day range, twelve-month context and the follow-up that decides the next session.
ANURAS in Focus: Anupam Rasayan India Share Price Edges Lower to ₹1,163.40 on Rising Newsflow
Anupam Rasayan India (ANURAS) trades at ₹1,163.40, -6.80 (-0.58%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Maharashtra Scooters Share Price Ended Lower to ₹12,318.00 In Tuesday's Session — Volumes, 52-Week Range and What to Watch Next
Maharashtra Scooters (MAHSCOOTER) last traded at ₹12,318.00, -189.00 (-1.51%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
MAHSEAMLES in Focus: Maharashtra Seamless Share Price Traded Flat at ₹685.70 on Rising Newsflow
Maharashtra Seamless (MAHSEAMLES) last traded at ₹685.70, +0.65 (+0.09%) as the in-focus story plays out. Last-session board, day range, twelve-month context and the follow-up that decides the next session.
Maharashtra Seamless Traded Flat at ₹685.70 — Should Investors Read This as a Trend or a One-Day Move?
Maharashtra Seamless (MAHSEAMLES) last traded at ₹685.70, +0.65 (+0.09%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Why Motilal Oswal M50 Etf Share Price Sees 2.0x Volume Spike Today: the Brokerage Call Trigger, Explained
Motilal Oswal M50 Etf (MOM50) trades at ₹238.19, +2.58 (+1.10%). The brokerage-call trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Engineers India Ended Higher to ₹312.75 — Should Investors Read This as a Trend or a One-Day Move?
Engineers India (ENGINERSIN) last traded at ₹312.75, +3.15 (+1.02%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Galaxy Surfactants Share Price Saw 4.3x Volume Spike: What Is Driving GALAXYSURF In Friday's Session, and the Levels That Matter
Galaxy Surfactants (GALAXYSURF) last traded at ₹2,376.90, +44.10 (+1.89%) as the in-focus story plays out. Last-session board, day range, twelve-month context and the follow-up that decides the next session.
Aurobindo Pharma Ended Lower to ₹1,672.00 — Should Investors Read This as a Trend or a One-Day Move?
Aurobindo Pharma (AUROPHARMA) last traded at ₹1,672.00, -25.70 (-1.51%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Sun Pharma Adv.Res.Co.Ltd Share Price Ended Higher to ₹208.85 on M&A News — What It Means for Investors
Sun Pharma Adv.Res.Co.Ltd (SPARC) last traded at ₹208.85, +6.00 (+2.96%). The m&a trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Gland Pharma Jumped 3.24% to ₹2,989.70 After Brokerage Call Update — Levels, Volumes and the Follow-Up to Track
Gland Pharma (GLAND) last traded at ₹2,989.70, +93.70 (+3.24%) as the brokerage-call story plays out. Last-session board, day range, twelve-month context and the follow-up that decides the next session.
SPARC in Focus: Sun Pharma Adv.Res.Co.Ltd Share Price Ended Higher to ₹208.85 on Rising Newsflow
Sun Pharma Adv.Res.Co.Ltd (SPARC) last traded at ₹208.85, +6.00 (+2.96%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Why Ola Electric Mobility Share Price Ended Lower to ₹37.86 In Monday's Session: the Fundraise Trigger, Explained
Ola Electric Mobility (OLAELEC) last traded at ₹37.86, -0.62 (-1.61%). The fundraise trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Zydus Lifesciences Share Price Hit 52-Week High, Up 0.92%: What Is Driving ZYDUSLIFE In Monday's Session, and the Levels That Matter
Zydus Lifesciences (ZYDUSLIFE) last traded at ₹1,215.00, +11.10 (+0.92%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
NATCOPHARM in Focus: Natco Pharma Share Price Ended Lower to ₹828.55 on Rising Newsflow
Natco Pharma (NATCOPHARM) last traded at ₹828.55, -10.75 (-1.28%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Sun Pharma Adv.Res.Co.Ltd Edges Lower to ₹207.47 — Should Investors Read This as a Trend or a One-Day Move?
Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹207.47, -1.58 (-0.76%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
ZYDUSLIFE in Focus: Zydus Lifesciences Share Price Hit 52-Week High, Up 1.96% on Rising Newsflow
Zydus Lifesciences (ZYDUSLIFE) last traded at ₹1,203.90, +23.60 (+1.96%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Zydus Lifesciences Hit 52-Week High, Up 1.96% — Should Investors Read This as a Trend or a One-Day Move?
Zydus Lifesciences (ZYDUSLIFE) last traded at ₹1,203.90, +23.60 (+1.96%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Why Virtual Galaxy Infotech Share Price Jumped 3.69% to ₹146.50 In Friday's Session: the IPO Trigger, Explained
Virtual Galaxy Infotech (VGINFOTECH) last traded at ₹146.50, +5.40 (+3.69%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Corporate Action Story Puts Concord Biotech in Play: Share Price Opened Gap-Down at ₹1,540.20, and Here Is the Arithmetic
Concord Biotech (CONCORDBIO) last traded at ₹1,560.30, +27.90 (+1.79%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
CONCORDBIO Jumped 5.38% to ₹1,579.40: Inside the Corporate Action Story Moving Concord Biotech Shares
Concord Biotech (CONCORDBIO) last traded at ₹1,579.40, +85.00 (+5.38%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
SPARC in Focus: Sun Pharma Adv.Res.Co.Ltd Share Price Edges Up to ₹194.72 on Rising Newsflow
Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹194.72, +0.80 (+0.41%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
KRSNAA in Focus: Krsnaa Diagnostics Share Price Jumps 4.42% to ₹561.20 on Rising Newsflow
Krsnaa Diagnostics (KRSNAA) trades at ₹561.20, +24.80 (+4.42%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Momentum Story Puts Healthcare Glob. Ent. in Play: Share Price Opens Gap-Up at ₹678.30, and Here Is the Arithmetic
Healthcare Glob. Ent. (HCG) trades at ₹664.65, -13.65 (-2.05%) as the momentum story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
AUROPHARMA in Focus: Aurobindo Pharma Share Price Opens Gap-Up at ₹1,688.00 on Rising Newsflow
Aurobindo Pharma (AUROPHARMA) trades at ₹1,660.00, -19.80 (-1.19%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Piramal Pharma Edges Lower to ₹211.35 — Should Investors Read This as a Trend or a One-Day Move?
Piramal Pharma (PPLPHARMA) trades at ₹211.35, -1.14 (-0.54%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Piramal Pharma Share Price Edges Lower to ₹211.35: What Is Driving PPLPHARMA Today, and the Levels That Matter
Piramal Pharma (PPLPHARMA) trades at ₹211.35, -1.14 (-0.54%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
VIJAYA in Focus: Vijaya Diagnostic Cen Share Price Trades Flat at ₹1,502.10 on Rising Newsflow
Vijaya Diagnostic Cen (VIJAYA) trades at ₹1,502.10, +3.30 (+0.22%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Alembic Pharma Edges Lower to ₹810.05 — Should Investors Read This as a Trend or a One-Day Move?
Alembic Pharma (APLLTD) trades at ₹810.05, -6.35 (-0.78%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
SPARC in Focus: Sun Pharma Adv.Res.Co.Ltd Share Price Opens Gap-Up at ₹204.00 on Rising Newsflow
Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹200.58, -2.69 (-1.34%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Why Healthcare Glob. Ent. Share Price Jumps 3.03% to ₹712.20 Today: the Momentum Trigger, Explained
Healthcare Glob. Ent. (HCG) trades at ₹712.20, +21.60 (+3.03%). The momentum trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Sun Pharma Adv.Res.Co.Ltd Share Price Opens Gap-Up at ₹205.87: What Is Driving SPARC Today, and the Levels That Matter
Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹203.27, -2.60 (-1.28%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Sun Pharma Adv.Res.Co.Ltd Opens Gap-Up at ₹205.87 After M&A Update — Levels, Volumes and the Follow-Up to Track
Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹203.27, -2.60 (-1.28%) as the m&a story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Cohance Lifesciences Opens Gap-Up at ₹463.30 — Should Investors Read This as a Trend or a One-Day Move?
Cohance Lifesciences (COHANCE) trades at ₹456.60, -4.25 (-0.93%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
SUDEEPPHRM Hits 52-Week High, Up 2.75%: Inside the Momentum Story Moving Sudeep Pharma Shares
Sudeep Pharma (SUDEEPPHRM) trades at ₹1,329.30, +36.50 (+2.75%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Gland Pharma Sees 3.6x Volume Spike After OFS / Stake Sale Update — Levels, Volumes and the Follow-Up to Track
Gland Pharma (GLAND) trades at ₹2,932.40, +24.50 (+0.84%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Why Sudeep Pharma Share Price Hits 52-Week High, Up 2.75% Today: the Momentum Trigger, Explained
Sudeep Pharma (SUDEEPPHRM) trades at ₹1,329.30, +36.50 (+2.75%) as the momentum story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Why Gland Pharma Share Price Opens Gap-Down at ₹2,870.00 Today: the OFS / Stake Sale Trigger, Explained
Gland Pharma (GLAND) trades at ₹2,907.90, +39.50 (+1.36%). The ofs-/-stake-sale trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Sun Pharma Adv.Res.Co.Ltd Opens Gap-Up at ₹199.33 — Should Investors Read This as a Trend or a One-Day Move?
Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹196.98, -2.35 (-1.19%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
MANKIND in Focus: Mankind Pharma Share Price Edges Up to ₹2,419.20 on Rising Newsflow
Mankind Pharma (MANKIND) trades at ₹2,419.20, +36.30 (+1.50%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Bharti Airtel Drops 3.89% to ₹1,811.90 — Should Investors Read This as a Trend or a One-Day Move?
Bharti Airtel (BHARTIARTL) trades at ₹1,811.90, -70.50 (-3.89%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Natco Pharma Share Price Opens Gap-Up at ₹853.30: What Is Driving NATCOPHARM Today, and the Levels That Matter
Natco Pharma (NATCOPHARM) trades at ₹841.50, -12.30 (-1.46%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Sun Pharma Adv.Res.Co.Ltd Share Price Drops 4.20% to ₹199.33: What Is Driving SPARC Today, and the Levels That Matter
Sun Pharma Adv.Res.Co.Ltd (SPARC) trades at ₹199.33, -8.38 (-4.20%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
AUROPHARMA in Focus: Aurobindo Pharma Share Price Hits 52-Week High, Up 4.18% on Rising Newsflow
Aurobindo Pharma (AUROPHARMA) trades at ₹1,717.00, +71.70 (+4.18%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Emcure Pharmaceuticals Share Price Edges Lower to ₹1,869.40: What Is Driving EMCURE Today, and the Levels That Matter
Emcure Pharmaceuticals (EMCURE) trades at ₹1,869.40, -9.00 (-0.48%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.